ALEXANDRIA, Va., Feb. 12 -- United States Patent no. 12,221,487, issued on Feb. 11, was assigned to Ablynx N.V. (Ghent-Zwijnaarde, Belgium).

"Nucleic acids encoding CX3CR1-binding polypeptides comprising immunoglobulin single variable domains" was invented by Sanjaya Singh (Sandy Hook, Conn.), Alisa K. Waterman (Branford, Conn.), Erik Depla (Destelbergen, Belgium), Toon Laeremans (Dworp-Beersel, Belgium), Diane Van Hoorick (Laarne, Belgium) and Cedric Jozef Neotere Ververken (Merelbeke, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to CX3CR1-binding polypeptides, in particular polypeptides comprising specific immunoglobulin domains. The invention also relates to nucleic...